7 Results for "

RAMP2

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "RAMP2" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P1548
CAS No.: 101462-82-2
Synonyms: Human β-CGRP; CGRP-II (Human)
β-CGRP, human (Human β-CGRP) is one of calcitonin peptides, acts via the complex of calcitonin-receptor-like receptor (CRLR) and receptor-activity-modifying protein (RAMP), with IC50s of 1 nM and 300 nM for CRLR/RAMP1 and CRLR/RAMP2 in cells .
1
1 Cited Publications
Cat. No.: HY-P1548A
Synonyms: Human β-CGRP TFA; CGRP-II (Human) TFA
β-CGRP, human TFA (Human β-CGRP TFA) is one of calcitonin peptides, acts via the complex of calcitonin-receptor-like receptor (CRLR) and receptor-activity-modifying protein (RAMP), with IC50s of 1 nM and 300 nM for CRLR/RAMP1 and CRLR/RAMP2 in cells .
Cat. No.: HY-RS11639
Research Areas:  

Others

RAMP2 Human Pre-designed siRNA Set A contains three designed siRNAs for RAMP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-P1548B
Synonyms: Human β-CGRP acetate; CGRP-II (Human) acetate
β-CGRP, human acetate (Human β-CGRP acetate) is one of calcitonin peptides, acts via the complex of calcitonin-receptor-like receptor (CRLR) and receptor-activity-modifying protein (RAMP), with IC50s of 1 nM and 300 nM for CRLR/RAMP1 and CRLR/RAMP2 in cells .
Cat. No.: HY-P88661

Host:  

Mouse

Application:  

IHC-P, FC

Reactivity:  

Human

Cat. No.: HY-P88661A
Synonyms: Receptor activity-modifying protein 2, Calcitonin-receptor-like receptor activity-modifying protein 2, CRLR activity-modifying protein 2, RAMP2

Host:  

Mouse

Application:  

IHC-P, FC

Reactivity:  

Human

Cat. No.: HY-183142
CAS No.: 2252341-45-8
Target:  

CGRP Receptor

Research Areas:  

Cancer

CLR/RAMP3-receptor antagonist-1 is a selective antagonist of the CLR/RAMP3 receptor (CLR/RAMP3, AM2 receptor), with pIC50 values of 5.86, 9.21 and 9.07 against AM1 (CLR/RAMP2), AM2 (CLR/RAMP3) and CGRP (CLR/RAMP1) receptors, respectively. CLR/RAMP3-receptor antagonist-1 reduces the levels of pancreatic cancer progression markers, induces apoptosis in vitro, and prolongs survival in mouse models of pancreatic cancer. CLR/RAMP3-receptor antagonist-1 can be used in pancreatic cancer-related research .